Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Draft Bill Expands FDA Regulatory Power Over Compounding Pharmacies April 30, 2013 Martha Garcia Add Your Comments New legislation was proposed Friday that would tighten the FDA’s controls on compounding pharmacies; an effort that follows the ongoing meningitis outbreak that started last fall and has killed 53 people across 23 states. The legislation was proposed by a bipartisan group of U.S. senators as an answer to tightening restraints on compounding pharmacies that ship drugs across state lines, following last year’s regulatory failures that allowed the New England Compounding Center (NECC) to ship nearly 20,000 contaminated doses of steroid pain medication across state lines, sickening more than 700 people nationwide. As a result of the outbreak, NECC later lost its license and has since declared bankruptcy in the face of mounting fungal meningitis lawsuits filed on behalf of individuals who have developed infections after receiving the contaminated epidural steroid injections. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Regulation of Compounding Manufacturers The proposed legislation would create a new class of drug maker, distinguishing standard compounding pharmacies from pharmacies like NECC. Traditionally, compounding pharmacies mix drugs using an individual’s prescription, to fill a need for local hospitals and medical providers. However, a new bread of compounding pharmacies like NECC have surfaced in recent years, making large quantities of drugs and shipping them to doctors nationwide to keep on hand for future use. Until now, both types of compounding pharmacies were regulated and licensed by state boards. Under the new legislation, the FDA would have more room to regulate the new “compounding manufacturers” who create large quantities of drugs without prescriptions, shipping them across state lines. This new type of compounding pharmacy, the compounding manufacturer, would be required to register with the FDA, report any problems reported by patients or physicians to the FDA and would be required to pay an annual fee to offset the cost of inspections conducted by the agency. In an effort to keep them from competing with actual drug manufacturers, this new classification of compounding pharmacy would not be allowed to compound biological products made from live organisms or mix other complex drugs. They would also be prohibited from compounding FDA approved drugs, unless the drugs are scarce. Officials estimate that of the approximate 2,800 compounding pharmacies in the United States, roughly 500 would fall into the new classification. The focus on categorizing these pharmacies would be whether they manufacture drugs at high risk of contamination and sell those drugs across state lines, not their sales volume. Legislation Concerns Scrutiny concerning the FDA’s role in regulating compounding pharmacies has become a high concern in Congress, following last year’s outbreak. Senators have criticized the FDA for not being more aggressive in its regulation of NECC and other similar compounding pharmacies. While the FDA has agreed with that assessment, it has attempted to argue that it lacks the authority to regulate these pharmacies, which fall under state board oversight. Following the outbreak, the FDA has begun to attempt to regulate other compounding pharmacies and faced strong resistance from other compounding pharmacies who failed to comply with FDA inspections. Inspection resistance led FDA commissioner Margaret Hamburg to call for new FDA powers in regulating the compounding pharmacy industry. A move which may have helped, in part, to prompt legislators to formulate the new bill. Lawmakers remain hopeful concerning the proposed legislation. However, in past years other attempts to offer the FDA more power to regulate compounding pharmacies faced criticism and staunch opposition. Compounding pharmacy support groups, like the International Academy of Compounding Pharmacists, lobbied against a similar bill in 2007, eventually defeating the movement. Tags: Compounding Pharmacy, Congress, Fungal Meningitis Image Credit: ||| More Lawsuit Stories Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks June 20, 2025 Retired Talcum Powder Judge May Be Appointed To Address Renewed Expert Motions June 20, 2025 New Study Links Ultra-Processed Foods Intake With Multiple Adverse Health Effects June 20, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025) Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Lawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (Posted: today) A Depo-Provera lawsuit blames the active ingredient, DMPA, for an increased risk of the development of brain tumors. MORE ABOUT: DEPO-PROVERA LAWSUITOrtho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)Pfizer Requests Depo-Provera Lawsuit Coordination as Mass Tort in Pennsylvania State Court (06/10/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: 2 days ago) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 3 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)